Disturbing miR-182 and -381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4.
Inactivated LRRC4 has been clinically detected in gliomas, and promoter hypermethylation has been implicated as the mechanism of inactivation in some of those tumors. Our previous researches indicated that LRRC4 is a target gene of miR-381, the interaction of miR-381 and LRRC4 is involved in glioma...
Main Authors: | Hailin Tang, Zeyou Wang, Qing Liu, Xiaoping Liu, Minghua Wu, Guiyuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3880275?pdf=render |
Similar Items
-
MiR-185 Targets the DNA Methyltransferases 1 and Regulates Global DNA Methylation in human glioma
by: Wang Rong, et al.
Published: (2011-09-01) -
Dexmedetomidine protects PC12 cells from ropivacaine injury through miR-381/LRRC4 /SDF-1/CXCR4 signaling pathway
by: Ying Xue, et al.
Published: (2020-06-01) -
The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells
by: Zeyou Wang, et al.
Published: (2016-11-01) -
Novel Therapy for Glioblastoma Multiforme by Restoring LRRC4 in Tumor Cells: LRRC4 Inhibits Tumor-Infitrating Regulatory T Cells by Cytokine and Programmed Cell Death 1-Containing Exosomes
by: Peiyao Li, et al.
Published: (2017-12-01) -
Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia
by: Piqiang Zhang, et al.
Published: (2020-09-01)